What was the result of the meta-analysis of the ACEi and ARBs trials on kidney outcomes?
A meta-analysis of trials examining ACEi or ARBs on kidney outcomes found a 49% decrease (RR: 0.51; 95% CI: 0.38 0.69) in the composite outcome, ESKD and a doubling of serum creatinine with 769 participants.